I imagine there are multiple reasons why developing therapies for children is more difficult, but what would be the adequate level of funding? Less than 0.25% of cancer deaths correspond to patients younger than 20 when diagnosed (and I guess the low incidence is one of the reasons why developing new treatments is difficult).

[ At least in the UK, according to http://www.cancerresearchuk.org/health-professional/cancer-s... ]